Non-cardiac comorbidities in heart failure with reduced, mid-range and preserved ejection fraction
Year: 2018
Type: article
Abstract: Background Comorbidities play a major role in heart failure. Whether prevalence and prognostic importance of comorbidities differ between heart failure with preserved ejection fraction (HFpEF), mid-range (HFmrEF) or reduced ejection fraction (HFrEF) is unknown. Methods Patients from index (n = 2516) and validation cohort (n = 1738) of The BIOlogy Study to TAilored Treatment in Chronic Heart Failure (BIOSTAT-CHF) were pooled. Eight non-cardiac comorbidities were assessed; diabetes mellitus, thyroid dysfunction, obesity, anaemia, chronic kidney disease (CKD, estimated glomerular filtration rate < 60 mL/min/1.73 m 2 ), COPD, stroke and peripheral arterial disease. Patients were classified based on ejection fraction. The association of each comorbidity with quality of life (QoL), all-cause mortality and hospitalisation was evaluated. Results Patients with complete comorbidity data were included (n = 3499). Most prevalent comorbidity was CKD (50%). All comorbidities showed the highest prevalence in HFpEF, except for stroke. Prevalences of HFmrEF were in between the other entities. COPD was the comorbidity associated with the greatest reduction in QoL. In HFrEF, almost all were associated with a significant reduction in QoL, while in HFpEF only CKD and obesity were associated with a reduction. Most comorbidities in HFrEF were associated with an increased mortality risk, while in HFpEF only CKD, anaemia and COPD were associated with higher mortality risks. Conclusions The highest prevalence of comorbidities was seen in patients with HFpEF. Overall, comorbidities were associated with a lower QoL, but this was more pronounced in patients with HFrEF. Most comorbidities were associated with higher mortality risks, although the associations with diabetes were only present in patients with HFrEF.
Authors: Koen W. Streng, Jan F. Nauta, Hans L. Hillege, Stefan D. Anker, John G. Cleland, Kenneth Dickstein, Gerasimos Filippatos, Chim C. Lang, Marco Metra, Leong L. Ng, Piotr Ponikowski, Nilesh J. Samani, Dirk J. van Veldhuisen, Aeilko H. Zwinderman, Faiez Zannad, Kevin Damman, Peter van der Meer, Adriaan A. Voors
Institutions: University Medical Center Groningen, University of Groningen, Universitätsmedizin Göttingen, Harefield Hospital, Imperial College London, Stavanger University Hospital, University of Bergen, National and Kapodistrian University of Athens, University General Hospital Attikon, University of Dundee, Ninewells Hospital, University of Brescia, University of Leicester, Glenfield Hospital, NIHR Leicester Biomedical Research Centre, Wroclaw Medical University, Amsterdam UMC Location University of Amsterdam, Inserm, Centre Hospitalier Régional et Universitaire de Nancy, Université de Lorraine
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Keywords: heart failure, comorbidities, heart failure with preserved ejection fraction, heart failure with reduced ejection fraction, mid-range ejection fraction, chronic kidney disease, obesity, chronic obstructive pulmonary disease, anemia, diabetes mellitus, stroke, peripheral arterial disease, thyroid dysfunction, quality of life, all-cause mortality, hospitalization
Open Access status: hybrid
Estimated APC paid: $3,970
OpenAlex ID: W2795697937
